期刊文献+

尿毒清颗粒联合舒血宁注射液治疗早期糖尿病肾病疗效观察

原文传递
导出
摘要 目的探讨尿毒清颗粒联合舒血宁注射液治疗早期糖尿病肾病的临床疗效。方法将60例早期糖尿病肾病患者随机分为对照组和治疗组,每组30例,对照组给予常规治疗,治疗组在此基础上加用尿毒清颗粒联合舒血宁注射液,疗程均为3周。检测尿微量白蛋白排泄率(UAER)等变化情况。结果两组治疗后尿素氮(BUN)均无明显变化(P>0.05),治疗组其余各指标均较治疗前下降(P<0.05),UAER显著改善(P<0.01)。结论尿毒清颗粒联合舒血宁注射液治疗早期糖尿病肾病疗效确切。
作者 陈勇
出处 《中国误诊学杂志》 CAS 2011年第9期2130-2131,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

二级参考文献15

  • 1The 15th annual report of the United States Renal Data Systems. USRDS Coordinating Center. 2003.
  • 2Screening for type 2 diabetes. World Health Organization.2003
  • 3Rabkin R.Diabetic nephropathy. Clin Cornerstone, 2003, 5:1-11.
  • 4Bakris GL, Weir MR, Shanifar S, et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med, 2003,163: 1555-1565.
  • 5Sahay BK, Sahay RK. Hypertension in diabetes. J Indian Med Assoc, 2003,101: 12, 14,15, 44.
  • 6Lea JP,Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc, 2002, 94(8 Suppl): 7S-15S.
  • 7Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure:the JNC 7 report. JAMA, 2003, 289: 2560-2572.
  • 8Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end-stage renal disease in patients with type 2diabetes and nephropathy: the RENAAL study. Kidney Iht,2003,63: 1499-1507.
  • 9Ruggenenti P, Perna A, Gherardi G, et al. Chronic proteinuric nephropathies:outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis, 2000, 35: 1155-1165.
  • 10Jude EB,Anderson SG, Cruickshank JK,et al. Natural history and prognostic factors of diabetic nephropathy in type 2diabetes. Q J Med, 2002, 95:371-377.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部